SCHEMBL6834007

SCHEMBL6834007

O=C(CN1C(=O)c2ccccc2C1=O)NCCn1c(-c2ccccc2)nc2c(C(F)(F)F)nc3ccccc3c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
USP2 O75604 1/20 0.38
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833915 0.87 MTNR1A (0.39) LMNAKDM4ESMN1; SMN2HTTL3MBTL1
SCHEMBL6833826 0.86 AVPR1B (0.39) KDM4EHTTL3MBTL1HSD17B10MTNR1A
SCHEMBL6838401 0.86 MTNR1A (0.40) SMN1; SMN2HTTL3MBTL1MTNR1AMTNR1B
SCHEMBL6838145 0.84 MTNR1A (0.39) LMNAKDM4EHTTL3MBTL1ALOX15
SCHEMBL6838095 0.84 MTNR1A (0.50) LMNAMEN1KMT2AKDM4EL3MBTL1
Fumaric Acid SCHEMBL6838681 0.81 MTNR1A (0.37) LMNAKDM4EHTTL3MBTL1ALOX15
Fumaric Acid SCHEMBL6838685 0.81 MTNR1A (0.37) LMNAKDM4EHTTL3MBTL1ALOX15
SCHEMBL6833799 0.76 TLR7 (0.46) LMNASMN1; SMN2HTTMTNR1AMTNR1B
SCHEMBL6837676 0.75 EGFR (0.42) LMNAKMT2ASMN1; SMN2ALDH1A1RAB9A
SCHEMBL6833994 0.75 CYP3A4 (0.35) LMNAPKMMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 LMNA 4507/4885PKM 1728/4885MEN1 2204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.